Nancy Denyes, General Counsel at aTYR PHARMA INC (ATYR), bought 5,000 shares at $1.86 ($9K) on 2024-06-05, disclosed to the SEC on 2024-06-06.
Open-market purchase of $9k ATYR by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LIFE | SELL | 2020-05-28 | $1K | — | Filing → |